Hypotensive Effect of Heated Water-based Exercise in Older Individuals with Hypertension

Carregando...
Imagem de Miniatura
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2019
Editora
GEORG THIEME VERLAG KG
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
NGOMANE, Awassi Yophiwa
FERNANDES, Bianca
CIOLAC, Emmanuel Gomes
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, v.40, n.4, p.283-291, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Blood pressure (BP) and hemodynamic response to heated water-based (HEx) vs. land-based exercise (LEx) were assessed in 15 (6 men) older hypertensives (age 66.4 +/- 4.9yr) under pharmacological treatment. Participants were randomly assigned to perform 30min of moderate-intensity HEx (walking inside the pool), LEx (walking on a treadmill) and non-exercise control (CON) intervention. Resting BP, arterial stiffness, endothelial reactivity and heart rate variability (HRV) were measured before, immediately after, and 45min after interventions. 24-h ambulatory BP monitoring was performed after interventions. Resting systolic (but not diastolic) BP reduced 9.9 +/- 3.1mmHg ( P <0.01) 45min after HEx only. 24-h systolic and diastolic, daytime diastolic and nightime systolic BP were lower ( P <0.05) after HEx than both LEx and CON. Daytime systolic BP was also lower ( P <0.05) after HEx than CON. Nighttime diastolic was not different between interventions. HEx-induced ambulatory BP reduction ranged 4.5 +/- 1.3mmHg (24-h diastolic BP) to 9.5 +/- 3.0mmHg (nighttime systolic BP), and persisted for 18/11h in systolic/diastolic BP, when compared with CON. No significant changes in arterial stiffness, endothelial reactivity and HRV were found during any intervention. These results suggest that HEx may have important implications for managing BP in older hypertensive under pharmacological treatment.
Palavras-chave
aging, arterial stiffness, endothelial function, exercise, heart rate variability, hypertension
Referências
  1. Ayme K, 2014, INT J CARDIOL, V176, P1377, DOI 10.1016/j.ijcard.2014.07.271
  2. Bocalini DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180216
  3. Carvalho VO, 2009, CIRC J, V73, P1871, DOI 10.1253/circj.CJ-09-0333
  4. Castro RE, 2016, MED SCI SPORT EXER, V48, P804, DOI 10.1249/MSS.0000000000000846
  5. Cider A, 2006, EUR J HEART FAIL, V8, P308, DOI 10.1016/j.ejheart.2005.08.001
  6. Cider A, 2003, EUR J HEART FAIL, V5, P527, DOI 10.1016/S1388-9842(03)00048-5
  7. Ciolac EG, 2011, EUR J CARDIOV PREV R, V18, P824, DOI 10.1177/1741826711398426
  8. Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72
  9. Ciolac EG, 2008, CLINICS, V63, P753, DOI 10.1590/S1807-59322008000600008
  10. Ciolac EG, 2009, INT J CARDIOL, V133, P381, DOI 10.1016/j.ijcard.2008.02.005
  11. Ciolac EG, 2016, SPORTS MED, V46, P1239, DOI 10.1007/s40279-016-0507-z
  12. Ciolac EG, 2015, MED SCI SPORT EXER, V47, P1321, DOI 10.1249/MSS.0000000000000553
  13. Ciolac EG, 2013, CLINICS, V68, P710, DOI 10.6061/clinics/2013(05)20
  14. Ciolac EG, 2012, AM J CARDIOVASC DIS, V2, P102
  15. Cornelissen VA, 2013, J HYPERTENS, V31, P639, DOI 10.1097/HJH.0b013e32835ca964
  16. Cruz LGD, 2017, CIRC J, V81, P339, DOI 10.1253/circj.CJ-16-0870
  17. Day L M, ARTERY RES, V7, P119
  18. Dimeo F, 2012, HYPERTENSION, V60, P653, DOI 10.1161/HYPERTENSIONAHA.112.197780
  19. Guimaraes GV, 2013, BLOOD PRESS MONIT, V18, P342, DOI 10.1097/MBP.0000000000000000
  20. Guimaraes GV, 2014, INT J CARDIOL, V172, P434, DOI 10.1016/j.ijcard.2014.01.100
  21. Guimaraes GV, 2010, HYPERTENS RES, V33, P627, DOI 10.1038/hr.2010.42
  22. Harriss DJ, 2017, INT J SPORTS MED, V38, P1126, DOI 10.1055/s-0043-124001
  23. He W, 2016, INT POPULATION REPOR, P95
  24. Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154
  25. James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809
  26. Lewington S, 2002, LANCET, V360, P1903
  27. Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c
  28. Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912
  29. Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6
  30. Ngomane AY, 2017, MED SCI SPORT EXER, V49, P907, DOI 10.1249/01.mss.0000519467.61230.31
  31. Pardini R, 2001, REV BRASILEIRA CIENC, V9, P45
  32. Pascoalino LN, 2015, J HEART LUNG TRANSPL, V34, P693, DOI 10.1016/j.healun.2014.11.013
  33. Pescatello LS, 2004, J HYPERTENS, V22, P1881, DOI 10.1097/00004872-200410000-00009
  34. Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A
  35. Pierce DR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00073
  36. Pradhapan P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00208
  37. Schmid JP, 2007, HEART, V93, P722, DOI 10.1136/hrt.2006.094870
  38. Siasos G, 2016, EUR J PREV CARDIOL, V23, P1565, DOI 10.1177/2047487316647185
  39. Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006